Description
Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously.
RETATRUTIDE
$79.00
Triple-receptor agonist (GIP/GLP-1/glucagon) at the research frontier.
Obsidian Labs
Research Use Peptides
$79.00
Triple-receptor agonist (GIP/GLP-1/glucagon) at the research frontier.
Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously.
Reviews
There are no reviews yet.